Patents by Inventor Assunta Imperato

Assunta Imperato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of riluzole and levodopa for the treatment of Parkinson's disease
    Patent number: 6387936
    Abstract: The invention concerns a combination of levodopa and riluzole or a pharmaceutically acceptable salt of said compound and the use of said combination for treating Parkinson Disease.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: May 14, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Véronique Blanchard-Bregeon, Assunta Imperato, Saliha Moussaoui, Marie-Carmen Obinu, Michel Reibaud
  • Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction
    Patent number: 6245791
    Abstract: A method for the prevention or treatment of cerebellar dysfunction, particularly cerebellar ataxia, by the use of riluzole or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: June 12, 2001
    Assignee: Aventis Pharma S.A.
    Inventors: Andrees Bohme, Alain Boireau, Thierry Canton, Assunta Imperato
  • Heterocyclic carboxamide compounds effective in the treatment of drug abuse
    Patent number: 6150387
    Abstract: This invention relates to the use of heterocyclic carboxamide compounds for preventing or reducing self-administration, by a human or animal patient, of a drug or a substance capable of giving rise to pharmacomania or to overuse. The preferred types of drugs or substances are nicotine, caffeine, benzodiazepines, narcotics, and hallucinogens.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: November 21, 2000
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Andrees Bohme, Marie-Christine Dubroeucq, Walter Fratta, Claude Guyon, Assunta Imperato, Franco Manfre
  • Use of pyrrolidine derivatives in the treatment of alcoholism
    Patent number: 5935980
    Abstract: The use of pyrrolidine derivatives of general formula (I) for treating chronic alcoholism or conditions caused by alcohol abuse is described.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: August 10, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventor: Assunta Imperato
  • Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
    Patent number: 5519044
    Abstract: The invention provides use of a 5HT-3 antagonist in the manufacture of a medicament suitable for the prevention or reduction of dependence on a dependence-inducing agent.
    Type: Grant
    Filed: December 7, 1993
    Date of Patent: May 21, 1996
    Assignee: Sandoz Ltd.
    Inventors: Assunta Imperato, Dietmar Romer
  • Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
    Patent number: 5272168
    Abstract: The invention provides use of a 5HT-3 antagonist in the manufacture of a medicament suitable for the prevention or reduction of dependence on a dependence-inducing agent.
    Type: Grant
    Filed: January 15, 1993
    Date of Patent: December 21, 1993
    Assignee: Sandoz Ltd.
    Inventors: Assunta Imperato, Dietmar Romer
  • Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
    Patent number: 5198459
    Abstract: The invention provides use of a 5HT-3 antagonist in the manufacture of a medicament suitable for the prevention or reduction of dependence on a dependence-inducing agent.
    Type: Grant
    Filed: June 6, 1991
    Date of Patent: March 30, 1993
    Assignee: Sandoz Ltd.
    Inventors: Assunta Imperato, Dietmar Romer
  • New use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
    Patent number: 5039680
    Abstract: The invention provides use of a 5HT-3 antagonist in the manufacture of a medicament suitable for the prevention or reduction of dependence on a dependence-inducing agent.
    Type: Grant
    Filed: January 19, 1990
    Date of Patent: August 13, 1991
    Assignee: Sandoz Ltd.
    Inventors: Assunta Imperato, Dietmar Romer